Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Stem Cell Cryopreservation Market Revenue Growth Supported By A CAGR Of 10.17% Through 2030

The market for cryopreserving stem cells has experienced significant expansion. Projections indicate a rise from $4.17 billion in 2025 to $4.99 billion in 2026, demonstrating a compounded annual growth rate of 19.8%. This upward trend during the past period is largely due to the proliferation of stem cell banking programs, the escalating utilization of cryopreservation techniques in scientific research, a surge in in-vitro fertilization (IVF) and reproductive therapies, a growing need for extended cell storage solutions, and advancements in cryogenic preservation technologies.

The market for preserving stem cells through freezing is poised for substantial expansion in the upcoming years, projecting a rise to $10.17 billion by 2030, driven by a compelling compound annual growth rate of 19.5%. This projected surge is largely fueled by the escalating acceptance of regenerative medicine treatments, augmented investments in biobanking facilities, a heightened need for personalized medicine storage, the broadening of clinical cell therapy development, and a greater emphasis on established storage methodologies. Key developments anticipated during this same timeframe include a greater call for extended stem cell storage solutions, increased utilization of sophisticated cryoprotective agents, the growing implementation of automated freezing systems, an enlargement of stem cell banking services, and a more pronounced dedication to safeguarding cell viability.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30405&type=smp

Stem Cell Cryopreservation Market Growth Drivers And Industry Catalysts

The escalating incidence of conditions characterized by progressive decline in tissue or organ structure and function is anticipated to be a primary catalyst for the expansion of the stem cell cryopreservation market. This rise in degenerative diseases is largely attributable to an expanding elderly demographic, as age-related cellular and tissue degradation increases susceptibility to these ailments. Stem cell cryopreservation offers a method for preserving the viability of stem cells over extended periods, thereby ensuring a dependable supply for regenerative treatments aimed at repairing or replacing compromised tissues affected by degenerative conditions. As an illustration, the Alzheimer’s Association reported in March 2023 that roughly 6.7 million Americans aged 65 and above were affected by Alzheimer’s dementia, with projections indicating this figure could reach 13.8 million by 2060. Consequently, the heightened occurrence of degenerative diseases directly fuels the increasing demand within the stem cell cryopreservation sector.

Stem Cell Cryopreservation Market Segment Breakdown: Which Categories Generate The Most Revenue?

The stem cell cryopreservation market covered in this report is segmented –

1) By Type: Embryonic Stem Cell, Adult Stem Cell, Induced Pluripotent Stem Cell

2) By Application: Cell Freezing Media, Equipment And Consumables

3) By End User: Biopharmaceutical Companies, Research Institutes, Blood Banks, In Vitro Fertilization (IVF) Clinics

Subsegments:

1) By Embryonic Stem Cell: Human Embryonic Stem Cell, Mouse Embryonic Stem Cell, Primate Embryonic Stem Cell, Other Embryonic Stem Cells

2) By Adult Stem Cell: Hematopoietic Stem Cell, Mesenchymal Stem Cell, Neural Stem Cell, Epithelial Stem Cell

3) By Induced Pluripotent Stem Cell: Fibroblast-Derived iPSC, Blood Cell-Derived iPSC, Epithelial Cell-Derived iPSC

#Stem Cell Cryopreservation Market Trends Influencing Long-Term Demand

Companies actively participating in the stem cell cryopreservation sector are emphasizing the creation of novel approaches, including sophisticated cryopreservation mediums and automation-compatible freezing apparatus, aimed at improving cell survival rates after thawing and expediting advancements in stem cell treatments. These cutting-edge cryopreservation mediums are meticulously crafted solutions designed to safeguard stem cells throughout the freezing and thawing phases, thereby preserving their viability and operational capacity. Concurrently, automation-friendly freezing systems represent equipment or methodologies instituted to facilitate large-scale, repeatable, and automated cell freezing processes. Illustrating this trend, in April of 2024, the American biotechnology firm Pluristyx, Inc. introduced PluriFreeze, a proprietary cryopreservation medium. This sophisticated product is specifically engineered to optimize the freezing and thawing procedures for pluripotent stem cells and other delicate cell categories, thereby guaranteeing superior post-thaw viability and maintaining their functional integrity. Owing to its completely synthetic composition, free from animal-derived elements and possessing low viscosity, PluriFreeze is exceptionally well-suited for automated and extensive cell production operations. The system is further supported by the PluriPrep wash solution, which is devoid of DMSO and permits extended processing windows. Formulated from components designated as Generally Recognized as Safe (GRAS), this medium ensures dependable, consistent, and secure cryopreservation suitable for both research endeavors and clinical applications. This release, by synergizing effortlessly with platforms like PluriBank, fortifies the entire stem cell cryopreservation pipeline, offering effective and scalable solutions that span from initial laboratory investigations to eventual clinical deployment.

Stem Cell Cryopreservation Market Key Players And Strategic Industry Positioning

Major companies operating in the stem cell cryopreservation market are Thermo Fisher Scientific Inc., Danaher Corporation, Corning Incorporated, Lonza Group Ltd., Sartorius AG, Eppendorf SE, Vitalant Inc., BioLife Solutions Inc., Cryoviva Biotech Private Limited., HiMedia Laboratories Private Limited, Cryo-Cell International Inc., Celularity Inc., PromoCell GmbH, Creative Biolabs Inc., StemCyte Inc., Reprocell Inc., OriGen Biomedical Inc., American CryoStem Corporation, Ossium Health Inc., Pluristyx Inc.

Access The Complete Stem Cell Cryopreservation Market Report:

https://www.thebusinessresearchcompany.com/report/global-stem-cell-cryopreservation-market-report

Stem Cell Cryopreservation Market Regional Analysis And Leading Geography

North Americawas the largest region in the stem cell cryopreservation market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the stem cell cryopreservation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model